4-83462485-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The ENST00000321945.12(ABRAXAS1):āc.1214G>Cā(p.Arg405Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,612,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R405Q) has been classified as Likely benign.
Frequency
Consequence
ENST00000321945.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABRAXAS1 | NM_139076.3 | c.1214G>C | p.Arg405Pro | missense_variant | 9/9 | ENST00000321945.12 | NP_620775.2 | |
ABRAXAS1 | NM_001345962.2 | c.887G>C | p.Arg296Pro | missense_variant | 8/8 | NP_001332891.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABRAXAS1 | ENST00000321945.12 | c.1214G>C | p.Arg405Pro | missense_variant | 9/9 | 1 | NM_139076.3 | ENSP00000369857 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000152 AC: 38AN: 249830Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135100
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1460072Hom.: 0 Cov.: 30 AF XY: 0.0000647 AC XY: 47AN XY: 726286
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152080Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74300
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 29, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at